Connect with us

COVID-19

The Telegraph reports COVID shots may have helped cause over 3 million excess deaths

Published

4 minute read

From LifeSiteNews

By Emily Mangiaracina

A BMJ study found that there have been over three million excess deaths in 47 countries from 2020 to 2022 and acknowledged that the COVID shots may have had ‘detrimental effects,’ the Telegraph reported.

The popular U.K. media outlet the Telegraph published a report Tuesday admitting that a recent peer-reviewed study shows COVID shots “may have helped fuel a rise in excess deaths” numbering over three million.

The medical journal BMJ Public Health conducted a data analysis of 47 countries, largely in Europe and North America, which found high excess death rates for three continuous years since the outbreak of COVID-19.

“This is unprecedented and raises serious concerns,” the researchers concluded. They noted that it was “likely” that “containment measures” increased the death rate, but that it is difficult to prove the fatal effects of restricted health care and economic decline.

The researchers also pointed out that the COVID shots, like the containment measures, may have had “detrimental effects that cause inferior outcomes,” especially since clinical trials have shown that recipients of the mRNA vaccines have shown substantially higher instances of adverse events than control groups.

Using a statistical method called Karlinsky and Kobak’s estimate model, the study compared death rates in given countries from 2020 to 2022 to death data from 2015 to 2019, accounting for seasonal variation in mortality rates.

The researchers found 1,033,122 excess deaths – 11.5% more than expected – recorded in the countries in 2020, when the COVID-19 outbreak began and measures such as lockdowns and social distancing were enacted.

In 2021, when the COVID shots were widely made available for public use and “containment” measures continued, 1,256,942 excess deaths – just under 14% more than expected – were recorded.

And in 2022, when the COVID shot rollout continued and most containment measures were lifted, 808,392 excess deaths were recorded, although the researchers pointed out there is a typical data reporting lag of months or even years in many countries.

The Telegraph highlighted the fact that the “onset of excess mortality in early 2021” in Germany synchronized with the rollout of COVID shots, according to German researchers who have said this calls for “further investigation.”

The researchers noted that “side effects linked to the Covid vaccine had included ischaemic stroke, acute coronary syndrome and brain haemorrhage, cardiovascular diseases, coagulation, haemorrhages, gastrointestinal events and blood clotting,” the Telegraph said.

The British media outlet also pointed to the repeated warnings of Gordon Wishart, chief medical officer at Check4Cancer, that delaying cancer diagnoses would cause increased deaths.

“It was predicted early in the lockdown period that limited access to healthcare for non-Covid conditions would lead to delays in the diagnosis and treatment of time-critical conditions such as cancer, cardiac disease, diabetes and dementia and that this would lead to excess deaths from these conditions,” Wishart said, The Telegraph reported.

According to NHS England data, the cancer rate fell from 521 per 100,000 people in the year before lockdowns to 456 from 2020-2021, “suggesting around 45,000 cancers were missed in the first pandemic year.”

“Government leaders and policy makers need to thoroughly investigate underlying causes of persistent excess mortality and evaluate their health crisis policies,” the researchers concluded.

U.S. citizens: Demand Congress investigate soaring excess death rates

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

COVID-19

Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’

Published on

From LifeSiteNews

By Conservative Treehouse

The director of National Intelligence revealed gain-of-function ties to US funding, which could indicate that the US helped bankroll the supposed COVID lab leak.

In this segment of a remarkable interview by Megyn Kelly, Director of National Intelligence Tulsi Gabbard discusses the current Intelligence Community (IC) research into the origin of the SARS-CoV-2 pandemic (aka, COVID-19).

Gabbard talks about the U.S. government funding of “gain-of-function” research, which is a soft sounding phrase to describe the weaponization of biological agents.

Gabbard notes the gain-of-function research taking place in the Wuhan lab was coordinated and funded by the United States government, and the IC is close to making a direct link between the research and the release of the COVID-19 virus.

Additionally, Gabbard explains the concern of other biolabs around the world and then gets very close to the line of admitting the IC itself is politically weaponized (which it is but would be stunning to admit).

 

Continue Reading

COVID-19

Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

Published on

From LifeSiteNews

By Nicolas Hulscher, MPH

A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna

A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.

The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:

Study Overview

  • Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
  • Intervention: Two doses of either:
    • BNT162b2 (Pfizer-BioNTech)
    • mRNA-1273 (Moderna)
  • Follow-up Duration: 12 months after second dose.
  • Comparison: Head-to-head between Pfizer vs. Moderna recipients.
  • Main Outcomes:
    • All-cause mortality
    • Cardiovascular mortality
    • COVID-19 mortality
    • Non-COVID-19 mortality

All-cause mortality

Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.

  • Pfizer Risk: 847.2 deaths per 100,000 people
  • Moderna Risk: 617.9 deaths per 100,000 people
  • Risk Difference:
    ➔ +229.2 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.37 (i.e., 37% higher mortality risk with Pfizer)
  • Odds Ratio (Adjusted):
    ➔ 1.384 (95% CI: 1.331–1.439)

Cardiovascular mortality

Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.

  • Pfizer Risk: 248.7 deaths per 100,000 people
  • Moderna Risk: 162.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +86.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.53 (i.e., 53% higher cardiovascular mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.540 (95% CI: 1.431–1.657)

COVID-19 mortality

Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.

  • Pfizer Risk: 55.5 deaths per 100,000 people
  • Moderna Risk: 29.5 deaths per 100,000 people
  • Risk Difference:
    ➔ +26.0 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.88 (i.e., 88% higher COVID-19 mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.882 (95% CI: 1.596–2.220)

Non-COVID-19 mortality

Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.

  • Pfizer Risk: 791.6 deaths per 100,000 people
  • Moderna Risk: 588.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +203.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.35 (i.e., 35% higher non-COVID mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.356 (95% CI: 1.303–1.412)

Biological explanations

The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:

The paper hypothesizes differences between Pfizer and Moderna may be due to:

  • Different lipid nanoparticle compositions
  • Differences in manufacturing, biodistribution, or storage conditions

Final conclusion

Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.

Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.

As the authors conclude:

These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.

Reprinted with permission from Focal Points.

Continue Reading

Trending

X